Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BRISTOL-MYERS SQUIBB COMPANY
09/20BRISTOL MYERS SQUIBB : FDA Grants Bristol-Myers Squibb Priority Review for Metastatic Mela..
MT
09/20BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Review Brist..
BU
09/20Bristol Myers Gets FDA Priority Review of Relatlimab/Opdivo Combo in Melanoma
DJ
09/17BRISTOL MYERS SQUIBB : Combination Therapy Gets EMA Committee's Backing for Treating Gastr..
MT
09/17BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherap..
BU
09/17Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo with Chemotherapy for Pa..
CI
09/17Bristol Myers Gets Positive CHMP Opinion for Opdivo in Gastric, Esophageal Cancers
DJ
09/16Bristol-Myers Squibb Down Nine Consecutive Days, on Pace for Longest Losing Streak Sinc..
DJ
09/16BRISTOL MYERS SQUIBB : Reports Data From Phase 3 Trial of Opdivo, Yervoy Combination
MT
09/16BRISTOL MYERS SQUIBB : Five-Year Data from CheckMate -214 Show Opdivo (nivolumab) Plus Yer..
BU
09/16Bristol Myers Squibb Announces Five-Year Data from Checkmate -214 Show Opdivo Plus Yerv..
CI
09/16EXELIXIS : Says New Exploratory Data from Late-Stage Trial Show Potential of Kidney Cancer..
MT
09/13BRISTOL MYERS SQUIBB : Says Phase 3 Trial of Opdivo Combined With Yervoy for Organ Tissue ..
MT
09/13BRISTOL MYERS SQUIBB : According to New Multinational Survey, Healthcare Providers Believe..
BU
09/13BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Durable Ov..
BU
09/13Bristol-Myers Squibb Company Announces Three-Year Data from the Checkmate -743
CI
09/13TreeFrog Therapeutics announced that it has received Ç64 million in funding from Bpifra..
CI
09/10BRISTOL MYERS SQUIBB : Shares Research Supporting Correlation Between New York Heart Assoc..
BU
09/09BRISTOL MYERS SQUIBB : Maintains Cash Dividend at $0.49 per common share, payable on Nov. ..
MT
09/09BRISTOL MYERS SQUIBB : Announces Dividend
BU
09/09Bristol Myers Squibb Announces Quarterly Dividend, Payable on November 1, 2021
CI
09/08BOLT BIOTHERAPEUTICS : Bristol Myers Squibb to Study Combo Therapy for HER2-Expressing Sol..
MT
09/08BRISTOL MYERS SQUIBB : Bolt Biotherapeutics Announces Clinical Collaboration with Bristol ..
AQ
09/08Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Stud..
CI
09/08BRISTOL MYERS SQUIBB : to Report Results for Third Quarter 2021 on October 27, 2021
BU
09/08BRISTOL MYERS SQUIBB : More than 230 Bristol Myers Squibb Employees Pedal Across the U.S. ..
BU
09/08BRISTOL MYERS SQUIBB : Research at ESMO 2021 Demonstrates Clinical Benefits of Immunothera..
BU
09/07UPDATED STATEMENT : Bristol Myers Squibb on Coronavirus (COVID-19)
PU
09/07BRISTOL MYERS SQUIBB : to Take Part in Morgan Stanley 19th Annual Global Healthcare Confer..
BU
09/03BRISTOL MYERS SQUIBB : Pfizer Alliance is pleased with the decision by the U.S. Court of A..
PU
09/03BRISTOL MYERS SQUIBB : Appeals Court Rules in Favor of Bristol-Myers Squibb in Eliquis Pat..
MT
09/03NOVARTIS' : Sandoz Canada Launches Generic Version of Bristol Myers' Blood Cancer Drug Rev..
MT
08/27BRISTOL MYERS SQUIBB : Sixth Circuit Limits Exercise Of Personal Jurisdiction In FLSA Coll..
AQ
08/26MARKET CHATTER : US Appeals Court Overturns $1.2 Billion Verdict Against Gilead Sciences, ..
MT
08/25Cardior Pharmaceuticals GmbH announced that it has received Ç64 million in funding from..
CI
08/23BRISTOL MYERS SQUIBB : Says FDA Accepts Supplemental Biologics License Application for Acu..
MT
08/23BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Review Brist..
BU
08/23Bristol-Myers Squibb Company Announces U.S. Food and Drug Administration Accepts for Pr..
CI
08/23Bristol Myers Gets FDA Priority Review of Orencia in Acute Graft-Vs-Host Disease
DJ
08/20BRISTOL MYERS SQUIBB : Gets FDA Approval for Opdivo to Treat Urothelial Carcinoma
MT
08/20STREET COLOR : Bristol-Myers Squibb Confirms FDA Approves Opdivo For Treatment of Urotheli..
MT
08/20BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo« (nivolumab) for ..
BU
08/20Bristol Myers Squibb Announces U.S. Food and Drug Administration Approves Opdivo« for t..
CI
08/20Bristol Myers Gets FDA Expanded OK of Opdivo in High-Risk Urothelial Carcinoma
DJ
08/19BRISTOL MYERS SQUIBB : Ide-Cel CAR T Cell Therapy Gets European Approval for Multiple Myel..
MT
08/19BRISTOL MYERS SQUIBB : Receives European Commission Approval for Abecma (Idecabtagene Vicl..
BU
08/19Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vic..
CI
08/19Bristol Myers Gets Conditional Marketing Authorization for Abecma
DJ
08/17STREET COLOR : Berkshire Hathaway Takes New Position in Organon, Dumps Biogen, Axalta, and..
MT
08/17BRISTOL MYERS SQUIBB : Two Cancer Therapy Applications Receive European Medicines Agency V..
MT
08/17BRISTOL MYERS SQUIBB : EMA Validates Bristol Myers Squibb's Applications for Opdivo (nivol..
BU
08/17Bristol Myers Squibb Announces EMA Validates its Applications for Opdivo + Yervoy and O..
CI
08/17BRISTOL MYERS SQUIBB : EMA Validates Two Opdivo Applications
DJ
08/16THIS WEEK AT THE NINTH : Class Objections And Robocalls
AQ
08/10BRISTOL MYERS SQUIBB : and Five Leading Historically Black Colleges and Universities Launc..
BU
08/09Bristol-Myers Squibb Company Announces Resignation of Michael Bonney from the Board
CI
08/05BRISTOL MYERS SQUIBB : Significant Insider Sales Reported in Shares of Bristol-Myers Squib..
MT
08/05Zymergen Names Chief Commercial Officer
MT
08/04BRISTOL MYERS SQUIBB : Significant Insider Sales in Shares of Bristol-Myers Squibb (BMY) E..
MT
08/04INSIDER TRENDS : 90-Days of Insider Buying at Bristol-Myers Squibb Reduced with Share Sale
MT
08/04INSIDER TRENDS : Insider Disposition at Bristol-Myers Squibb Scaling Back 90-Days of Buyin..
MT
08/03INSIDER TRENDS : Bristol-Myers Squibb Insider Converts Option/Derivative Security Sells Po..
MT
08/03INSIDER TRENDS : Bristol-Myers Squibb Insider Disposition Scales Back 90-Days of Buys
MT
08/03INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of Bristol-Myers Squ..
MT
08/03BRISTOL MYERS SQUIBB : Completes Sale of Manufacturing Facility in Couvet, Switzerland
BU
08/03BRISTOL MYERS SQUIBB : Statement on Istodax« (romidepsin) Relapsed/Refractory Peripheral T..
PU
08/03WuXi STA Pharmaceutical Co., Ltd completed the acquisition of Manufacturing Facility in..
CI
07/30BRISTOL MYERS SQUIBB : Receives European Commission Approval for Cancer Treatment Opdivo
MT
07/30BRISTOL MYERS SQUIBB : Receives European Commission Approval for Opdivo (nivolumab) as Adj..
BU
07/30Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treat..
CI
07/30Bristol Myers Says EC Approves Opdivo as Adjuvant Treatment in Esophageal or Gastroesop..
DJ
07/29BRISTOL MYERS SQUIBB : Goldman Sachs Adjusts Price Target for Bristol-Myers Squibb to $94 ..
MT
07/29Tranche Update on Agios Pharmaceuticals, Inc.'s Equity Buyback Plan announced on March ..
CI
07/29BRISTOL MYERS SQUIBB : Morgan Stanley Lifts Price Target on Bristol-Myers Squibb to $71 Fr..
MT
07/28Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on Octob..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on BRISTOL-MYERS SQUIBB COMPANY
09/20/21